Prevalence of insomnia and associated factors among postpartum mothers in Mattu City, Southwest Ethiopia: a community-based study.

Publication date: Dec 04, 2024

Insomnia during the postpartum period has short-term and long-lasting effects on the health of the mother and her baby. Hence, this study assessed the prevalence of insomnia and its associated factors among postpartum mothers in Mattu City. A community-based cross-sectional study was conducted among randomly selected 451 postpartum mothers in Mattu City from May 1 to June 1, 2022. A structured questionnaire was used to conduct a face-to-face interview. Athens’s Insomnia Scale (AIS) standardized tool was used to measure insomnia. EpiData version 4. 4.2. 1 and Statistical Package for Social Sciences version 26 were used for data entry and analysis, respectively. Factors significantly affecting insomnia were identified using a binary logistic regression analysis at a p-value of less than 0. 05. The prevalence of insomnia was found to be 29. 3% (95% CI: 25, 33. 5). Parity (AOR = 3. 36; 95% CI: 1. 88, 5. 60), unplanned pregnancy (AOR = 6. 15; 95% CI: 5. 23, 11. 55), lack of postnatal follow-up (AOR = 3. 82; 95% CI: 1. 85, 7. 90), partner dissatisfaction with the gender of the current baby (AOR = 5. 73; 95% CI: 3. 23, 10. 2), partner daily alcohol use (AOR = 3. 12; 95% CI: 1. 66), and postpartum intimate partner violence (AOR = 2. 60; 95% 4. 67) were found to be factors significantly associated with insomnia. Generally, three in ten mothers were suffering from insomnia in the study area. Therefore, health professionals and health extension workers need to endorse and enhance the counseling of the postpartum mother and her partner jointly. In addition, the media and other concerned bodies should focus on the identified factors to overcome them.

Open Access PDF

Concepts Keywords
Athens Adolescent
Ethiopia Adult
June Cross-Sectional Studies
Mother Ethiopia
Psychiatry Ethiopia
Female
Humans
Insomnia
Mattu
Mothers
Postpartum
Postpartum Period
Pregnancy
Prevalence
Prevalence
Risk Factors
Surveys and Questionnaires
Young Adult

Semantics

Type Source Name
disease MESH insomnia
disease MESH unplanned pregnancy
drug DRUGBANK Ethanol
disease MESH violence
drug DRUGBANK Pentaerythritol tetranitrate
pathway REACTOME Reproduction
drug DRUGBANK Coenzyme M
disease MESH mental illnesses
disease MESH depression
disease MESH anxiety
disease MESH alcoholism
pathway KEGG Alcoholism
disease MESH postpartum depression
disease MESH psychosis
disease MESH suicidal ideation
disease MESH maternal educational status
disease MESH marital status
disease MESH critically ill
disease IDO process
disease MESH tics
disease IDO quality
disease IDO history
disease MESH complications
drug DRUGBANK Aspartame
disease IDO facility
drug DRUGBANK Ilex paraguariensis leaf
disease MESH substance use
disease IDO country
disease MESH psychological stress
disease MESH sleep quality
disease MESH loneliness
disease MESH COVID 19
disease IDO symptom
drug DRUGBANK Trestolone
disease MESH Sleep disorders
disease MESH colic
disease IDO intervention
disease MESH insufficient sleep
disease MESH excessive daytime sleepiness
drug DRUGBANK Filgrastim

Original Article

(Visited 1 times, 1 visits today)